Mealey's (April 20, 2023, 1:54 PM EDT) -- WASHINGTON, D.C. — The drug company that holds the new drug application (NDA) for the abortion drug mifepristone on April 19 urged the U.S. Supreme Court to stay a district court order staying approval of the drug in order to preserve the status quo or to grant certiorari and hear the case before the court’s current term ends....